When Chronic Pain Leads to Long-Term Medication Use
Chronic pain can affect nearly every part of daily life, from sleep and mobility to work, relationships, and emotional well-being. Medications may play an important role in managing persistent pain, but some patients eventually begin looking for ways to rely less heavily on long-term pain medicines, particularly opioids. At Pain & Vascular Institute in Fox River Grove, IL, patient education can help individuals better understand the range of approaches used in modern pain management, including treatments that target how pain signals are processed.
Neuromodulation is one such approach. Rather than depending entirely on medication circulating throughout the body, neuromodulation uses targeted electrical stimulation to influence nerve activity associated with pain. Spinal cord stimulation (SCS) is a commonly used form of neuromodulation for certain chronic pain conditions. FDA-approved SCS systems are designed to help manage difficult-to-treat chronic pain by delivering electrical stimulation near the spinal cord.
How Neuromodulation Changes the Pain Signal
Pain begins with communication between nerves, the spinal cord, and the brain. When tissue is injured or nerves become irritated, electrical and chemical signals travel through the nervous system. The brain interprets those signals as pain. With some chronic pain conditions, this signaling can continue long after the original injury has healed or can result from ongoing nerve dysfunction.
Neuromodulation attempts to change this communication. With spinal cord stimulation, thin leads are positioned near specific areas of the spinal cord and connected to a small pulse generator. The system sends controlled electrical impulses that alter pain-related nerve activity before those signals are fully processed by the brain. Different devices may use different stimulation patterns, frequencies, and programming strategies, allowing treatment to be adjusted according to the patient’s response.
The goal is not necessarily to eliminate every sensation of pain. Instead, treatment typically aims to reduce pain enough to improve function and quality of life. For some people, meaningful pain reduction can make walking, exercising, sleeping, working, and participating in rehabilitation easier.
Why Better Pain Control May Reduce Medication Dependence
Long-term pain medications are often prescribed because pain remains difficult to control through other approaches. If another treatment begins providing meaningful relief, a patient’s medication needs may change. Neuromodulation therefore offers a fundamentally different strategy: instead of simply adding another medication, it targets the nervous system pathways involved in pain.
Research suggests spinal cord stimulation may be associated with reductions in opioid use for some patients. A nationwide analysis of 8,497 adults who underwent SCS found that 60.4% had some reduction in opioid use within one year, while 17% stopped opioids entirely. However, these results do not mean every person receiving neuromodulation will be able to discontinue pain medication.
A 2026 systematic review and meta-analysis likewise found SCS was associated with reduced opioid consumption and increased odds of opioid cessation at 12 months, but the authors rated the certainty of the evidence as very low. This distinction is important: neuromodulation may support medication reduction in appropriately selected patients, but getting completely “off” pain medication cannot be guaranteed.
Medication Reduction Should Be a Gradual Medical Process
Successful neuromodulation does not mean patients should suddenly stop taking prescribed pain medications. This is especially important with opioids and certain other medicines that can cause withdrawal symptoms when discontinued abruptly. Medication changes should be planned with the healthcare professional responsible for prescribing and monitoring those medications.
When pain improves, a clinician may determine that gradually reducing a medication is appropriate. The pace of that process can vary considerably. Factors such as the medication being taken, dosage, duration of treatment, other health conditions, pain severity, and the patient’s response to neuromodulation can all influence the plan.
Reducing medication may also be only one part of the treatment goal. A meaningful outcome could include taking a lower dose, using medication less frequently, sleeping better, becoming more physically active, or completing daily activities with greater independence. Pain management is generally more successful when progress is evaluated according to function and quality of life rather than medication use alone.
The Trial Period Helps Patients Evaluate the Therapy
An important feature of spinal cord stimulation is that patients typically undergo a trial before receiving a permanent implanted system. During the trial, temporary leads are placed and connected to an external stimulation device. Patients then evaluate how well stimulation controls their pain during normal daily activities.
The trial gives both the patient and medical team an opportunity to determine whether neuromodulation produces meaningful improvement before proceeding with implantation. Pain reduction is important, but clinicians may also consider whether the patient is sleeping better, moving more comfortably, or relying less on certain pain-management strategies. FDA information on SCS systems notes that patients who do not obtain effective pain relief during trial stimulation should not proceed with implantation of certain systems.
If the trial provides sufficient benefit, permanent implantation may be considered. The device can then be programmed and adjusted over time based on the patient’s response. Follow-up remains important because chronic pain can change, and stimulation settings may need modification.
Who Might Be Considered for Neuromodulation?
Neuromodulation is generally considered for selected patients with chronic, difficult-to-manage pain rather than as the first treatment for every painful condition. Depending on the device and clinical situation, spinal cord stimulation may be considered for certain forms of persistent back or leg pain, neuropathic pain, pain following spine surgery, nonsurgical back pain, and painful diabetic neuropathy. Specific indications vary among devices.
Before recommending neuromodulation, clinicians typically review the patient’s diagnosis, previous treatments, medical history, current medications, psychological and functional factors, and treatment goals. Patients must also be appropriate candidates for the implantation procedure and capable of operating or managing the stimulation system.
Neuromodulation also carries potential risks. As with other implanted medical devices, complications can occur, including infection, bleeding, discomfort around implanted components, lead movement or malfunction, and the need for additional procedures. These considerations should be discussed carefully before treatment.
Building a Broader Strategy for Life With Less Pain
Neuromodulation is best understood as one component of comprehensive chronic pain management rather than a stand-alone cure. Even when stimulation provides substantial relief, patients may benefit from physical therapy, appropriate exercise, behavioral pain-management techniques, sleep improvement, weight management, or treatment of underlying medical conditions.
The broader goal is often to create enough pain control for a person to participate more fully in life. If better pain management also makes it possible to safely reduce long-term medication, that can become an additional benefit. Current evidence supports the possibility of reduced opioid use after SCS in some patients, although individual outcomes vary and more high-quality research is needed.
Taking the Next Step With Chronic Pain Management
Living with chronic pain can sometimes create a cycle in which medication becomes increasingly central to getting through the day. Neuromodulation provides another way of approaching persistent pain by targeting the nervous system signals involved rather than relying solely on medication. For carefully selected patients, successful treatment may provide better pain control, improved function, and an opportunity to discuss reducing certain medications under medical supervision.
Patients considering changes to a long-term pain treatment plan should have an individualized discussion with qualified healthcare professionals about their diagnosis, previous treatments, medication use, and goals. Pain & Vascular Institute in Fox River Grove, IL, recognizes the importance of patient education in helping individuals understand modern approaches to chronic pain and make informed decisions about their care.
Resources
Pollard, E. M., Lamer, T. J., Moeschler, S. M., et al. (2019). The Effect of Spinal Cord Stimulation on Pain Medication Reduction in Intractable Spine and Limb Pain: A Systematic Review of Randomized Controlled Trials and Meta-Analysis. Journal of Pain Research.
Adil, S. M., Charalambous, L. T., Spears, C. A., et al. (2020). Impact of Spinal Cord Stimulation on Opioid Dose Reduction: A Nationwide Analysis. Neurosurgery.
D’Souza, R. S., et al. (2026). Change in Opioid Use Following Spinal Cord Stimulation: A Systematic Review and Meta-Analysis. Regional Anesthesia & Pain Medicine.
